Vikram Dutt

Statistics

Publications

Citations

150

H-Index

Active since

2013

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Vikram Dutt is an author at Merck KGaA, Darmstadt (Germany) specializing in drug discovery, bruton tyrosine kinase, and tyrosine kinase inhibitor pharmacokinetics.

Publications per year

2013–2019

Publications

Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases

Richard D. Caldwell, Hui Qiu, Ben Askew et al. · Journal of Medicinal Chemistry · 2019 · 140 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies

Heike Hering, Danielle Graham, Solenne Ousson et al. · Molecular Neurodegeneration · 2013 · 10 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

1–2 of 2